Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L BLAKLEY

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1992
2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemiaV M Santana, J Mirro, C Kearns, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cellsL B Pemble, M G Lihou, R L Blakley, et al.
Journal of Medicinal Chemistry|June 1, 1984
Improved synthesis and antitumor activity of 2-bromo-2'-deoxyadenosineM C Huang, T L Avery, R L Blakley, et al.
Biochemistry|May 15, 1990
Dissociation constants for dihydrofolic acid and dihydrobiopterin and implications for mechanistic models for dihydrofolate reductaseG Maharaj, B S Selinsky, J R Appleman, et al.
The Journal of Biological Chemistry|April 1, 1994
Methotrexate-resistant variants of human dihydrofolate reductase. Effects of Phe31 substitutionsS K Chunduru, V Cody, J R Luft, et al.
Biochemistry|February 6, 1990
13C and 15N nuclear magnetic resonance evidence of the ionization state of substrates bound to bovine dihydrofolate reductaseB S Selinsky, M E Perlman, R E London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemiaV M Santana, J Mirro, F C Harwood, et al.
Biochemistry|February 5, 1991
Role of the conserved active site residue tryptophan-24 of human dihydrofolate reductase as revealed by mutagenesisW A Beard, J R Appleman, S M Huang, et al.
Archives of Biochemistry and Biophysics|April 1, 1983
Formation of 3-(2'-deoxyribofuranosyl) and 9-(2'-deoxyribofuranosyl) nucleosides of 8-substituted purines by nucleoside deoxyribosyltransferaseM C Huang, J A Montgomery, M C Thorpe, et al.
The Journal of Biological Chemistry|February 15, 1989
Atypical transient state kinetics of recombinant human dihydrofolate reductase produced by hysteretic behavior. Comparison with dihydrofolate reductases from other sourcesJ R Appleman, W A Beard, T J Delcamp, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1992
2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemiaV M Santana, J Mirro, C Kearns, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cellsL B Pemble, M G Lihou, R L Blakley, et al.
Journal of Medicinal Chemistry|June 1, 1984
Improved synthesis and antitumor activity of 2-bromo-2'-deoxyadenosineM C Huang, T L Avery, R L Blakley, et al.
Biochemistry|May 15, 1990
Dissociation constants for dihydrofolic acid and dihydrobiopterin and implications for mechanistic models for dihydrofolate reductaseG Maharaj, B S Selinsky, J R Appleman, et al.
The Journal of Biological Chemistry|April 1, 1994
Methotrexate-resistant variants of human dihydrofolate reductase. Effects of Phe31 substitutionsS K Chunduru, V Cody, J R Luft, et al.
Biochemistry|February 6, 1990
13C and 15N nuclear magnetic resonance evidence of the ionization state of substrates bound to bovine dihydrofolate reductaseB S Selinsky, M E Perlman, R E London, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 11, 1991
A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemiaV M Santana, J Mirro, F C Harwood, et al.
Biochemistry|February 5, 1991
Role of the conserved active site residue tryptophan-24 of human dihydrofolate reductase as revealed by mutagenesisW A Beard, J R Appleman, S M Huang, et al.
Archives of Biochemistry and Biophysics|April 1, 1983
Formation of 3-(2'-deoxyribofuranosyl) and 9-(2'-deoxyribofuranosyl) nucleosides of 8-substituted purines by nucleoside deoxyribosyltransferaseM C Huang, J A Montgomery, M C Thorpe, et al.
The Journal of Biological Chemistry|February 15, 1989
Atypical transient state kinetics of recombinant human dihydrofolate reductase produced by hysteretic behavior. Comparison with dihydrofolate reductases from other sourcesJ R Appleman, W A Beard, T J Delcamp, et al.
Pageof 8